Epigral Ltd
EPIGRALEpigral Ltd
EPIGRAL


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
23.07 | 6.13 | 0.26% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
27.82 | 3.16 | 1.50% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Epigral Limited (formerly Meghmani Finechem Limited) is a manufacturer of essential chemicals, primarily focused on the production of chlor alkali and its derivatives, used across various industries.
Investor Presentation
View olderPeers
Compare with peersGet more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||
---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 830.79 | 1,555.05 | 2,196.38 | 1,935.78 | 2,461.93 | |||||
Raw Materials | 386.52 | 759.41 | 1,211.76 | 1,071.60 | 1,754.54 | |||||
Power & Fuel Cost | 27.93 | 64.15 | 145.56 | 141.32 | ||||||
Employee Cost | 41.26 | 51.99 | 68.85 | 81.31 | ||||||
Selling & Administrative Expenses | 21.35 | 47.85 | 57.01 | 54.12 | ||||||
Operating & Other expenses | 90.22 | 118.06 | 16.30 | 99.64 | ||||||
EBITDA | 263.51 | 513.59 | 696.90 | 487.79 | 707.39 | |||||
Depreciation/Amortization | 73.54 | 85.91 | 108.95 | 123.56 | 128.99 | |||||
PBIT | 189.97 | 427.68 | 587.95 | 364.23 | 578.40 | |||||
Interest & Other Items | 29.11 | 44.27 | 65.50 | 73.49 | 55.19 | |||||
PBT | 160.86 | 383.41 | 522.45 | 290.74 | 523.21 | |||||
Taxes & Other Items | 60.02 | 130.63 | 169.17 | 94.88 | 175.14 | |||||
Net Income | 100.84 | 252.78 | 353.28 | 195.86 | 348.07 | |||||
EPS | 24.27 | 60.84 | 85.02 | 47.14 | 83.77 | |||||
DPS | 0.00 | 0.00 | 5.00 | 5.00 | 5.00 | |||||
Payout ratio | 0.00 | 0.00 | 0.06 | 0.11 | 0.06 |
Company Updates
Peers & Comparison
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Epigral Ltd | 40.99 | 6.13 | 0.26% |
Solar Industries India Ltd | 95.34 | 23.25 | 0.10% |
Linde India Ltd | 111.85 | 14.00 | 0.21% |
Deepak Nitrite Ltd | 37.65 | 6.33 | 0.34% |
Price Comparison
Compare EPIGRAL with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2024
Sep 2024
Oct 2024
Dec 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 3.12%
Top 5 Mutual Funds holding Epigral Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4709% | Percentage of the fund’s portfolio invested in the stock 0.89% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 50/105 (+22) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2990% | Percentage of the fund’s portfolio invested in the stock 0.20% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 87/103 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2197% | Percentage of the fund’s portfolio invested in the stock 1.09% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 26/110 (-6) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 7, 2025
Dividend/Share
₹2.50
Ex DateEx Date
Feb 7, 2025
Cash Dividend
Ex DateEx DateJul 2, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Jul 2, 2024
Cash Dividend
Ex DateEx DateJun 20, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Jun 20, 2023
Cash Dividend
Ex DateEx DateFeb 1, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Feb 1, 2023
Net profit of Epigral rose 111.15% to Rs 103.63 crore in the quarter ended December 2024 as against Rs 49.08 crore during the previous quarter ended December 2023. Sales rose 36.84% to Rs 645.24 crore in the quarter ended December 2024 as against Rs 471.52 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales645.24471.52 37 OPM %28.2925.99 - PBDT186.53104.81 78 PBT153.6273.93 108 NP103.6349.08 111 Powered by Capital Market - Live
Epigral has fixed 7 February 2025 as record date for payment of interim dividend for FY 2024-25. Powered by Capital Market - Live
Epigral announced that the Board of Directors of the Company at its meeting held on 27 January 2024, has recommended a Interim dividend of Rs.2.5 per share (i.e.25%), subject to the approval of the shareholders.Powered by Capital Market - Live
Epigral will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live
Net profit of Epigral rose 114.00% to Rs 81.30 crore in the quarter ended September 2024 as against Rs 37.99 crore during the previous quarter ended September 2023. Sales rose 30.93% to Rs 626.06 crore in the quarter ended September 2024 as against Rs 478.15 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales626.06478.15 31 OPM %28.5022.53 - PBDT157.4387.45 80 PBT125.1855.94 124 NP81.3037.99 114 Powered by Capital Market - Live
The Board of Epigral at its meeting held on 09 November 2024 has approved the expansion of production capacity of Chlorinated Polyvinyl Chloride Resin (CPVC Resin) and Epichlorohydrin at Dahej, Gujarat at an estimated capex of Rs 780 crore. Details: CPVC Resin - Proposed capacity addition 75,000 TPA (existing capacity 75,000 TPA; 65% capacity utilization) Epichlorohydrin - Proposed capacity addition 50,000 TPA (existing capacity 50,000 TPA; 80% capacity utilization) Powered by Capital Market - Live
Epigral will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
Epigral has allotted 15,19,180 equity shares at an issue price of Rs 2093.13 per equity share under QIP issue for a consideration of Rs 333.05 crore. With this allotment, the paid up equity share capital has increased to Rs 43,14,13,380 consisting of 4,31,41,338 equity shares. Powered by Capital Market - Live
The Board of Epigral at its meeting held on 14 August 2024 has approved fund raising up to Rs 500 crore through issue of securities on preferential allotment basis or qualified institutional placement. Powered by Capital Market - Live
Epigral will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 2.65%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant